Name: WU HENG

Academic qualifications:

  • 2000-2004 BSc. Dept. of Pharmacy, Chongqing Medical University, Chongqing, China
  • 2005-2008 MSc School of Pharmacy, Shenyang Pharmaceutical University, Liaoning, China
  • 2009-2012 PhD Dept of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong

Previous academic positions held:
  • 2008.6-2009.2 Research Assistant, School of Chinese Medicine, Hong Kong Baptist University
  • 2009.3-2009.9 Research Assistant, Dept. of Rehabilitation Sciences, Hong Kong Polytechnic University
Present academic position:
  • 2012- Postdoctoral Research Fellow (Honorary), Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University

Previous relevant research work:
  • ? Research area: Development of targeted delivery systems for RNAi-based or phytotherapy-based translational research in orthopaedic field
Publications (Representative publications in recent years):
  1. Zhang G, Guo BS, Wu H(Co-first author), Tang T, Zhang BT, et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Medicine 2012; 18: 307-314.
  2. Huang WH, Yang, ZJ, Wu H Wong, YF, Zhao, ZZ, Liu, L. Development of liposomal salbutamol sulfate dry powder inhaler formulation. Biol Pharm Bull. 2010: 33: 512-517.
  3. Yang XG, Wu H, Nie SF, Yan TX, Hong LJ, Pan WS. A new type of double-layered osmotic pump controlled release tablets of bezafibrate with poor water solubility and large dosage. Journal of drug delivery science and technology. 2008; 8: 273-277.